Article
Impact of XRCC1, GSTP1, and GSTM1 Polymorphisms on the Survival of Ovarian Carcinoma Patients Treated with Chemotherapy.
Oncology research and treatment - 1 Jan 2016
Zhai Xiang-Hong, Huang Jing, Wu Feng-Xia, Zhu Dong-Yi, Wang An-Cong
Abstract excerpt
BACKGROUND: Single nucleotide polymorphic variants of DNA repair genes may improve drug efficacy through altering expression levels of the encoded proteins. This study evaluated the influence of genetic polymorphism GSTP1 Ile105Val, GSTM1 (null/non-null) and 2 XRCC1 polymorphisms (Arg194Trp and Arg399Gln) on the survival of ovarian carcinoma patients treated with chemotherapy. METHODS: 106 patients received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
